Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants
Clinical trial NCT03210909 · COMPLETED
Trial details
- NCT number
- NCT03210909
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-22
- Primary completion
- 2017-07-20
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.